Pricing delay raises shortage of medicine, counterfeiting risks
At the heart of the crisis, they said, was the prolonged delay in deciding the prices of essential medicines. More than two years after the Drug Regulatory Authority of Pakistan (Drap) recommended price revisions for 105 hardship-category medicines, the federal government has yet to approve the proposals. Drap’s drug pricing committee concluded that the rising costs of imported raw materials, energy, packaging, transportation, labour, financing and currency depreciation had made the production of many essential medicines commercially unviable.
- ▪At the heart of the crisis, they said, was the prolonged delay in deciding the prices of essential medicines.
- ▪More than two years after the Drug Regulatory Authority of Pakistan (Drap) recommended price revisions for 105 hardship-category medicines, the federal government has yet to approve the proposals.
- ▪Drap’s drug pricing committee concluded that the rising costs of imported raw materials, energy, packaging, transportation, labour, financing and currency depreciation had made the production of many essential medicines commercially unviabl
Dawn files mainly under world. We currently carry 282 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Dawn |
| Canonical URL | https://www.dawn.com/news/2014936/pricing-delay-raises-shortage-of-medicine-counterfeiting-risks |
| Publication time | Mon, 13 Jul 2026 07:53:23 +0500 |
| Retrieval time | 2026-07-13T02:54:52.466Z |
| Last seen | 2026-07-13T02:54:52.466Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | ubxLyd4f2sCm |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Pricing delay raises shortage of medicine, counterfeiting risks Imran Ayub Published July 13, 2026 Updated July 13, 2026 07:53am 0 Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium, on August 9, 2019. — Reuters/File Listen to article 1x 1.2x 1.5x comments Join our Whatsapp Channel Add Dawn as a trusted source • Federal cabinet yet to decide on proposals despite Drap recommending price revisions for 105 hardship-category medicines over two years ago• Prolonged shortages creating opportunities for illegal suppliers to fill the gap, chemists’ body warns KARACHI: The prolonged shortage of more than 100 essential medicines, including life-saving drugs for cancer, heart disease and other serious illnesses, has created space for counterfeit and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Dawn.